The Federal Trade Commission sued the drug middlemen that well being plans use to maintain a lid on drug spending, accusing the companies of inflating the value of insulin.
in Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
Don't have an account? Register
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. GDPR Privacy policy
AcceptHere you'll find all collections you've created before.
